Angiotensin-converting enzyme inhibitors (ACEIs) are widely prescribed for cardiovascular and renal conditions, but a rare and potentially life-threatening complication is ACEI-induced angioedema, which results from bradykinin accumulation leading to increased vascular permeability and tissue swelling. Here, ACE is linked to angioedema.